Recombinant Anti-Methamphetamine Antibody (V3S-0723-FY169) (CAT#: V3S-0723-FY169)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This 4G9 antibody is a recombinant human IgG2b, κ antibody, and is a fully humanized products target for Methamphetamine. mAb4G9 recognizes METH and AMP with high affinity. mAb4G9 binds to METH with a affinity of 34 nM.
Clonality Monoclonal
Host Species Human
Target Species Non-species dependent
Affinity 34 nM
Isotype IgG2b, kappa

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target Methamphetamine
Alternative Name Methamphetamine; meth; aurora KA-7724; dl-methamphetamine; d-deoxyephedrine solution, dl-1-phenyl-2 (methylamino) propane solution; dl-methamphetaminesolution; rac-(R*)-N-methyl- 1-phenyl-2-propanamine; methyl-(1-methyl-2-phenyl-ethyl) amine; Nmethyl-1-p
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry